At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 216 enrolled
Drug / intervention
cyanoacrylate with pressure sensitive mesh +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter, Prospective, Randomized Controlled Study to Show Equivalence of DERMABOND PROTAPE to DERMABOND HVD for Closure of Simple, Thoroughly Cleansed, Trauma-induced Wounds in the Emergency Department
In Brief
A Phase 2 clinical trial evaluating cyanoacrylate with pressure sensitive mesh and cyanoacrylate for Lacerations. Completed, enrolled 216 participants across 9 sites.
Detailed Summary
This is a multicenter, prospective, randomized controlled study for the purpose of comparing DERMABOND PROTAPE to DERMABOND HVD for closure of wounds in the Emergency Department. The objective of this study is to demonstrate whether the incidence of wound closure for DERMABOND PROTAPE is equivalent to that measured for DERMABOND HVD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLacerations
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
First PostedOct 2007
Primary CompletionMar 2009
TodayJul 2026
First PostedOct 22, 2007
Enrollment StartAug 1, 2007
Primary CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 18.7 years ago
Interventions
cyanoacrylate with pressure sensitive meshdevice
Topical Skin Adhesive
cyanoacrylatedevice
Topical Skin Adhesive